Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001209191-23-009243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-14 | 2023-02-10+ | VRTX | WAGNER CHARLES F JR | EVP, CFO | F - Tax | $296.88 | -7,699 | 65.2K | -11% | -$2.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-10 | F | D | 2,707 | $294.33 | 70,183 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-13 | F | D | 4,992 | $298.26 | 65,191 | D | — | — |